Researchers
Grahovac, Jelena
Results 21-40 of 67
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | Cationic amphiphilic drugs as potential anticancer therapy for PDAC![]() | Živanović, Marija | Conference Paper | Mp. category will be shown later |
| 2022 | Antimelanoma Potential of New Telmisartan Analogues Without AT1 Receptor Activity![]() | Damjanovic, Ana | Conference Paper | Mp. category will be shown later |
| 2022 | Rilmenidine binds to and inhibits the activity of MDR pumps in pancreatic ductal adenocarcinoma![]() | Ostojić, Marija | Conference Paper | Mp. category will be shown later |
| 2021 | Anti-migratory properties of Nischarin agonist rilmenidine in pancreatic ductal adenocarcinoma![]() | Živić, Kristina | Conference Paper | Mp. category will be shown later |
| 2021 | Design of new telmisartan analogues without AT1 receptor antagonistic activity![]() | Dobričić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2021 | Drug repurposing in pancreatic ductal adenocarcinoma![]() | Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | Nischarin as a target for drug repurposing in solid tumors![]() | Ostojić, Marija | Conference Paper | Mp. category will be shown later |
| 2021 | The therapeutically inflamed tumor microenvironment drives melanoma progression.![]() | Bradshaw, Andrew M; Kuo, Erica; Grahovac, Jelena S | Conference Paper | Mp. category will be shown later |
| 2021 | Overview of the first year of the SARS-CoV-2 pandemic in Serbia and the Pirot County![]() | Čavić, Milena | Article | 53M53 |
| 2021 | Potential anti-metastatic activity of Imidazoline I1 receptor agonists in Pancreatic Ductal Adenocarcinoma![]() | Živić, Kristina | Conference Paper | Mp. category will be shown later |
| 2021 | Potential anti-MDR effect of rilmenidine in pancreatic ductal adenocarcinoma![]() | Ostojić, Marija | Conference Paper | Mp. category will be shown later |
| 2021 | Nischarin is expressed in pancreatic ductal adenocarcinoma and is a potential target for drug repurposing.![]() | Grahovac, Jelena S | Conference Paper | Mp. category will be shown later |
| 2021 | I1-imidazoline receptor ligand inhibits P-glycoprotein efflux in pancreatic ductal adenocarcinoma cells![]() | Ostojić, Marija | Conference Paper | Mp. category will be shown later |
| 2020 | Potential anti-melanoma activity of Imidazoline I1 receptor agonists![]() | Vidosavljević, Marija Z. | Conference Paper | 34 MNO za medicinske nauke (25.12.2024.)M34 |
| 2020 | Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance![]() | Erin, Nuray; Grahovac, Jelena | Article | 21a+M21a+ |
| 2020 | Synthesis and evaluation of anticancer activity of new 9-acridinyl amino acid derivatives![]() | Rupar, Jelena | Article | 23M23 |
| 2020 | Repurposing old drugs to fight multidrug resistant cancers![]() | Dinić, Jelena | Article | 21a+M21a+ |
| 2019 | Nischarin expression in melanoma![]() | Vidosavljević, Marija Z. | Conference Paper | Mp. category will be shown later |
| 2019 | Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics![]() | Grahovac, Jelena | Article | 21aM21a |
| 2019 | In silico analysis of nischarin expression in pancreatic ductal adenocarcinoma reveals its potential tumor-suppressive role![]() | Vidosavljević, Marija Z. | Conference Paper | Mp. category will be shown later |

